Noxopharm Limited (ASX:NOX)

Noxopharm Revenue

Noxopharm had revenue of 1.16M AUD in the half year ending December 31, 2024, a decrease of -65.44%. This brings the company's revenue in the last twelve months to 2.34M, down -39.52% year-over-year. In the fiscal year ending June 30, 2024, Noxopharm had annual revenue of 2.40M, down -60.06%.

• Revenue (ttm): 2.34M
• Revenue Growth: -39.52%
• P/S Ratio: 14.33
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 33.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.40M	-3.61M	-60.06%
Jun 30, 2023	6.01M	581.44K	10.71%
Jun 30, 2022	5.43M	-179.61K	-3.20%
Jun 30, 2021	5.61M	-2.67M	-32.29%
Jun 30, 2020	8.28M	4.53M	120.82%